[Treatment of disseminated intravascular coagulation with proteinase inhibitor].
Okamoto
K
K
Department of Surgery I, University of Occupational and Environmental Health.
Takeda
S
S
Ohsato
K
K
D000990:Antithrombin III / Q000627:therapeutic use*; D001550:Benzamidines; D004211:Disseminated Intravascular Coagulation / Q000188:drug therapy*; D004359:Drug Therapy, Combination; D005260:Female; D016670:Gabexate / Q000627:therapeutic use; D006023:Glycoproteins / Q000627:therapeutic use; D006146:Guanidines / Q000627:therapeutic use; D006493:Heparin / Q000627:therapeutic use; D006801:Humans; D008875:Middle Aged; D011480:Protease Inhibitors / Q000627:therapeutic use*; D011486:Protein C / Q000627:therapeutic use
D001550:Benzamidines; D006023:Glycoproteins; D006146:Guanidines; D011480:Protease Inhibitors; D011486:Protein C; D016670:Gabexate; D000990:Antithrombin III; D006493:Heparin; C028665:urinastatin; C032855:nafamostat